Source: FinanzNachrichten

Innate Pharma: Innate Pharma SA: Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team are scheduled to participate in the upcoming in...

Read full article »
Annual Revenue
$25-100M
Employees
100-250
Jonathan Dickinson's photo - Chairman & CEO of Innate Pharma

Chairman & CEO

Jonathan Dickinson

CEO Approval Rating

82/100

Read more